D-0258-2026 Class II Ongoing

Recalled by Advanced Pharmaceutical Technology, Inc. — Elmsford, NY

FDA drug recall D-0258-2026 was initiated by Advanced Pharmaceutical Technology, Inc. on Oct 3, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets. The recall status is ongoing. Affected quantity: 22,843 pellets.

Recall details

Product Type
Drugs
Report Date
Jan 21, 2026
Initiation Date
Oct 3, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,843 pellets

Product description

TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01

Reason for recall

Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.

Distribution pattern

GA, NY, TX, Puerto Rico, United Kingdom, Malta, Greece

Code information

Lot #: P-22-3, Exp 06-2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0258-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0258-2026. Report a data issue: hello@regdatalab.com.